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1. Introduction
The term “particle track” is commonly used in phys-
ics and in radiation biology in a variety of ways. Unless 
otherwise stated we will here use the words “particle 
track” to relate to the pattern of effect generated in the 
physical or biological detector by the passage of the pri-
mary particle and its associated secondary and higher 
generation δ-rays, such as the pattern of developed 
grains in nuclear emulsions or of inactivated cells in bi-
ological matter. We must be aware that the structure of 
the track depends on the end-point being observed. In a 
photographic emulsion the pattern of developed grains 
can be altered, both qualitatively and quantitatively by 
changes in developer composition, dilution, tempera-
ture, and time. We must expect that the track structure 
in emulsion would also be different if the observation 
was made with an ultra-violet microscope, for the size 
of a developed grain in relation to the wavelength of 
light also affects our perception of the “end-point.” The 
words “track,” “detector,” and “end-point” are intended 
to encompass all of these questions. 
In most cases of radiation exposure of the general 
public, or of occupational exposure of the individual, 
man is exposed to low levels of ionizing radiations. De-
spite the importance of low dose effects, no exact defi-
nition exists of what is meant by “low.” Typically low 
doses can be expected in environmental natural back-
ground exposure. In the context of this paper we speak 
of low doses when biological targets, such as cells or cell 
organelles, are traversed only by single charged parti-
cles and their associated δ-rays, and where intertrack in-
teractions can be neglected. Although man is exposed 
to low dose levels during his entire lifetime, only rough 
and controversial information can be derived from epi-
demiological investigations, the main problem being the 
synergistic interference of other environmental factors, 
e.g. co-carcinogens. Their interference can be minimized 
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Abstract
A radiation field is made up of a tangle of particle tracks, from the primary particle and secondary and higher generation electron 
interactions, well isolated at low doses and with multiple intersections in cell nuclei at high doses. Low dose effects in multicellu-
lar systems are therefore the sum of individual track structures. Until we can state with confidence the structure of a particle track 
in biological matter for all end-points of interest, at least as well as we can for nuclear emulsions, our knowledge of low dose ef-
fects should be regarded as uncertain and inadequate. In this context “track structure” means the response of physical and bio-
logical systems along the path of the particle, and depends on the observed end-point as well as on the identity of the particle. For 
mammalian cell killing and a few other biological end-points, track theory and experimental radiosensitivity parameters allow 
us to construct schematic models. If we take a particle track to consist of a sequence of inactivated cells strung along the path of a 
particle, neither electrons nor protons leave a track in a compact mammalian cell structure. At most there is an occasional killed 
cell at the end of the range of a proton or an electron where the particle stops in the nucleus of a cell, with probability less than 0.3 
for a proton, and less than 0.01 for an electron. The variety of potential targets whose size may be compared to the measured in-
activation cross-section and the lack of a fully consistent theory of RBE make it impossible to decide, from this information alone, 
whether cell killing is an individual (1-hit) or cooperative (many-hit) phenomenon, especially for electrons. A similar analysis of 
epidemiological data for cancer induction leads to probabilities and action cross-sections so low as to make a linear extrapolation 
implausible. In assigning quality factors at highest LET values we should consider that heavy ions inactivate cells, so that neither 
mutation nor transformation can represent a hazard. At low doses, when only isolated inactivated cells are produced whose func-
tion may be restored by repopulation, it is difficult to see why high LET radiations are assigned the highest quality factors.
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at higher radiation doses. Thus we may take uranium 
miner data as representative of the human reaction to 
radon decay products, or we may seek to improve the 
statistical accuracy of in-vitro cellular experiments, or of 
in-vivo animal experiments by high dose exposures. In 
general radiobiological experiments at high doses are 
reasonably well understood. The problem of radiation 
effects at low doses is therefore mainly the problem of 
extrapolation from high to low doses and must be based 
on theoretical assumptions. Depending on the theoret-
ical model used, different results are obtained at low 
doses [1]. It is therefore of utmost importance that the 
model used for extrapolation be testable at low doses 
with other detectors than biological systems, but whose 
response to radiation can be thought to parallel biologi-
cal response in some significant way. 
Experiment alone cannot provide an evaluation be-
tween dose and effect at levels of risk between 10–5 and 
10–7 Gy–1 needed for estimating radiation hazards to 
large populations [2]. 
In first approximation such effects arise from the in-
teraction of isolated energetic particles with biological 
targets. The low dose problem thus reduces to one of 
understanding the structure of a particle track in biolog-
ical matter for the required variety of end-points. Un-
til this can be accomplished our knowledge of the bio-
logical effects of low doses of ionizing radiations must 
be regarded as incomplete and speculative. Our knowl-
edge of the structure of particle tracks, of low dose ef-
fects, must come from an interpretation of high dose ef-
fects. For this reason cell killing is the main biological 
end-point considered in the present context. 
We have achieved a detailed model of cell killing by 
high LET radiations of demonstrated predictive value, 
and from which it is possible to extract a description of 
the structure of individual particle tracks (for this end-
point) from cell survival experiments at high doses with 
high LET radiations, such as beams of energetic heavy 
particles. However, mutagenesis and transformation to-
ward malignancy are also discussed here, for these rep-
resent the most important genetic and somatic hazards 
to man, though the experimental data are much more 
limited. 
Selective stains which reveal the tracks of charged 
particles for end-points of interest are either only par-
tially available or fail to ascertain that the effects are 
produced by single particles. To develop a picture of 
particle tracks in biology we must rely on a theory of bi-
ological response to radiations of different quality which 
is so constructed as to parallel a theory of particle tracks 
in nuclear emulsions, and which has been tested there 
and in a variety of other detectors. If the theory reason-
ably describes bulk effects in emulsions and other de-
tectors, and particle tracks in emulsions, while also de-
scribing bulk effects in biology, we may have some 
confidence in its extrapolation to particle tracks in biol-
ogy, and hence to the effects of low levels of radiation. 
Neither the theories which describe biological effects 
nor those which describe particle tracks in emulsion can 
be considered exact. Nevertheless they form a logical 
and computational structure which describes patterns of 
response of both biological and physical detectors to ar-
bitrary radiation fields. 
2. The 1-or-more hit detector
One-or-more hit detectors are characterized as hav-
ing an exponential response to dose and a decline in 
response with an increase in the “LET” of the incident 
radiation. 
The LET or “linear energy transfer” refers to a variety 
of restricted energy loss, or stopping power [3]. In the 
present context we imply no restriction and use the term 
LET to imply LET∞, the total rate of energy loss. 
To describe the properties of a 1- (or-more) hit detec-
tor theory requires knowledge of the following detector 
parameters: E0, the dose of gamma-rays at which there is 
an average of 1-hit per target, 0, the radius of the target 
(or κ = E00
2/2 × 10–2 J–1 m), and N0, the number density 
of targets, as well as the fact that the detector responds 
exponentially to radiations, in the form of the 1-or-more 
hit cumulative Poisson distribution. Together with the 
parameters of the ionizing particle, the radial distribu-
tion of the average local dose about the path of an ion, 
E¯(z*, β, t, 0), is needed. Here z* is the effective charge 
number of the ion, β is its speed relative to the speed of 
light, and t is the radial distance from the ion’s path to 
the center of the sensitive target. This distribution can be 
determined, either from measurement or by calculation 
from the properties of the medium, knowledge of δ-ray 
production, and of the subsequent electron interactions 
by which the energy lost by the heavy ion is transferred 
to the medium. 
Neither the parameters of the detector nor the radial 
distribution of dose are known precisely. Nevertheless 
the relationships are such that with some adjustment of 
parameters the overall form of the detector response to 
radiations of different “LET” and the structure of a par-
ticle track can be well fitted and even predicted by the 
theory. 
Typically the point distribution in local dose is given 
by an expression of the form
E(t) = C1z*2/β2t2                                 (1) 
from a radial distance t  15 nm to a maximal range tmax 
which lies in the neighborhood of
tmax = C2T 5/3,                                   (2) 
for a particle with kinetic energy per unit mass of value 
T. 
The only available experimental data [4,5] yield val-
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ues of C1, in water, in the neighborhood of 150 Gy nm2, 
within 25% fluctuation, while calculations [5,6,8] yield 
similar values. The constant C2 has the value 0.25 μm 
(MeV/amu)–5/3, for tmax is in μm when T is in MeV/amu. 
The average local dose E¯  can then be obtained by aver-
aging the point dose E over the sensitive site of radius 0 
centered at a radial distance t from the ion’s path. 
The theory of the 1-hit detector describes the behav-
ior of normally developed sensitive nuclear emulsions 
very well [9]. In essence we find the radial distribution 
in effect about an ion’s path from the radial distribution 
in local dose deposited by delta electrons [equation (l)] 
and the response of the detector to gamma-rays. For a 
uniform irradiation by gamma-rays with dose D, the 
dose-response relationship for a 1-hit detector is de-
scribed by 
P(D) = 1 – e–D/E0 .                           (3) 
Substituting E¯  for D, then enables us to calculate the 
linear density of developed grains, the track width or 
opacity, and to prepare computer models of particle 
tracks whose appearance compares well with micropho-
tographs of real tracks [10-13]. The radiosensitivity pa-
rameters of the emulsion are partly obtainable from the 
manufacturer (0 and N0), while E0 is sometimes mea-
sured from sensitometry after gamma-irradiation, and is 
sometimes fitted to the appearance of a particle track. 
The theory of the 1-hit detector also provides a very 
good description of the variation of the inactivation 
cross-sections of dry enzymes and viruses bombarded 
by heavy ion beams of different “LET.” Here the cross 
section σ is identified with the radially integrated prob-
ability P of inactivation of the targets, the enzyme or vi-
rus molecules, by the passage of a single ion: 
σ =  ⌠⌡0
tmax
 2πtP dt.                          (4) 
The decline in the yield of single strand break events 
in Φx-174 with an increase in “LET” [14] suggests that 
this is also a 1-hit process. Indeed single strand break 
events are defined by the authors as l-or-more breaks 
in a strand of the DNA double helix, as consistent with 
a l-or-more hit process. We have been able to fit these 
strand break data with the assumption that this process 
is described by the parameters E0 = 7 kGy and 0 = 10 
nm, not far from the parameters used in describing the 
inactivation of this virus [8]. To reasonable approxima-
tion radical production is also a 1-hit process, often of 
biological interest. 
Particle tracks in these biological 1-hit detectors, with 
inactivation as the biological end-point, will have simi-
lar appearance to particle tracks in 1-hit emulsions, ex-
cept for questions of scale. Indeed, exactly the same pro-
cedure used for emulsions [12] may be followed to yield 
the tracks in these biological detectors. The tracks will 
exhibit a grain-count regime, where the inactivated tar-
gets are openly strung along the ion’s path like beads 
on a string, when the probability P for inactivating tar-
gets traversed by the ion is small. In this case the inac-
tivation cross-section is also small when compared to 
the geometric cross-section. With increasing “LET,” as 
for a heavier or a slower ion, the inactivated targets are 
strung more closely together to present an increasingly 
filled “core” and a developing “track-width,” as the in-
activation cross-section exceeds the geometrical cross-
section of the target. Experiments with virus inactiva-
tion have found inactivation cross-sections more than 
an order of magnitude greater than the geometric cross-
section, while with emulsions the track width has been 
observed to be as much as 100 times the diameter of the 
undeveloped emulsion grain. 
In general, the tracks formed by charged particles in 
1-hit detectors are reasonably well understood. For such 
detectors we can claim to understand the effects of low 
doses of ionizing radiations. For 1-hit detectors the lin-
ear extrapolation to low dose is precisely correct. 
3. Biological cells
Our understanding of the structure of particle tracks 
in tissue, or in a matrix of biological cells in-vitro, poses 
a much more severe problem, different for every differ-
ent end-point. We do not truly know the size nor the lo-
cation of the sensitive targets, nor the number of these 
targets which must be hit to yield a particular end-point, 
aside from saying that they are in the nucleus or that 
they may be associated with the DNA or with the nu-
clear membrane [15]. Repair processes affect biological 
response, but we have no quantitative understanding 
of the effects of radiation on these processes. We can-
not be certain as to the shape of survival curves or of 
other dose-effect relationships, especially at low doses. 
Most analyses take the form of statistical curve fitting to 
high dose data, but these suffer from the inherent prob-
lem that the statistical models assume a homogeneous 
population, while experimental populations are hetero-
geneous [15]. It is currently popular (widely accepted) 
to use a linear-quadratic model, but such a model is by 
no means uniquely fitted to the available data. 
It has been argued that there is an intimate rela-
tionship between the shape of the survival curve after 
gamma-irradiation (low “LET”) and the “RBE” after 
high “LET” irradiations [17]. According to the ICRU [3], 
the Relative Biological Effectiveness (RBE) is defined as 
the ratio of the absorbed dose of a reference radiation 
to the absorbed dose of a test radiation to produce the 
same level of biological effect, other things being equal. 
The relationship between low and high LET radiations 
is based on the assumption inherent to track theory that 
the difference between low and high “LET” radiations 
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lies in (1) the temporal scale of the irradiation and (2) 
the microscopic concentration of local dose about the 
path of a heavy ion, and that sensitive targets respond to 
the dose of secondary electrons, irrespective of their or-
igin. To the extent that temporal differences may be ne-
glected, it follows that the probability for cell killing rel-
ative to the absorbed dose after gamma irradiation must 
be supralinear if an RBE greater than 1 is to be observed 
for any high “LET” radiation. For a more extensive dis-
cussion of these problems the reader is referred to refer-
ences 15, 17-20. 
When considering this problem from a theoretical 
viewpoint, it is imperative that we ask what the impli-
cations of a low “LET” survival curve are for the struc-
ture of particle tracks. These, after all, contain a high 
dose region close to the particle’s path where dose rate 
effects can be of consequence, and a low dose region far 
from the path where the question of dose rate is mean-
ingless, because it is unlikely that two electrons from 
the same ion pass through the same target or even the 
same cell nucleus. In the periphery of an ion’s path the 
only difference between delta-rays from a heavy ion 
and isolated Compton electrons from a photon irradi-
ation lies in their energy spectra. The question of ex-
trapolation of low doses of low LET radiations cannot 
be separated from the question of the RBE of high LET 
radiations. 
Physical detectors more complex than 1-hit detec-
tors have been treated as C-or-more hit systems, with 
four parameters, the hittedness C, E0, 0 (or κ) and N0. 
Application of the theory to biological cells whose sur-
vival curve after gamma-irradiation is represented by 
the multi-target single-hit statistical model, requires 
an additional parameter, the cross sectional area of the 
nucleus of the cell, for the sensitive sites are distrib-
uted throughout the nucleus, perhaps like “beans” in a 
“bean-bag.” These parameters are then m, the extrapo-
lation number of the gamma-ray survival curve, or the 
number of (1-hit) sensitive subcellular sites which must 
be inactivated to inactivate the cell, E0, the dose at which 
there is an average of 1-hit per target, κ, the value of 
z*2/4β2 at which the plateau value of the cellular inac-
tivation cross-section is achieved, σ0, the plateau value 
of the extrapolated cross-section (which approximates 
the geometrical cross-section of the cell nucleus), and 
N0, the number density of cells, needed for track simula-
tion, but not for survival curves. Thus for biological cells 
there are four fitted parameters from which the formu-
las of the theory must yield survival curves for an arbi-
trary radiation field for which we know the particle-en-
ergy spectrum [7,21]. The parameters are typically fitted 
to survival data for particles used in bombardments at 
energies less than 10 MeV/amu, and are then used for 
calculations for all radiation fields. 
The theory has been tested for neutron and pion irra-
diations [22], and irradiations with admixtures of neu-
trons and gamma-rays [23]. Most recently, in connec-
tion with a relatively primitive model of the secondary 
fragment production in heavy ion beams, it has been 
used to predict the inactivation of T-1 cells as a func-
tion of depth in energetic C, He, and Ar beams [24]. In-
deed calculations from in-vitro parameters have been 
shown to yield in-vivo values of the “RBE” vs. neutron 
dose for several different biological end-points [25], 
suggesting that the parameters of the model and the 
calculations made from it are valid for extrapolation 
to the structure of particle tracks in both in-vitro and 
in-vivo systems. In sum then, track structure theory in 
its extension to the “RBE” of high “LET” radiations has 
predictive value in spite of a not completely resolved 
conflict [17,19] between experiment and the demands 
of the theory in regard to the initial slope of the sur-
vival curve after gamma-irradiation. The success of 
the theory with heavy ion irradiations [24], and with 
mixed radiation environments [22,23] does account for 
the effects of particle track structure in high “LET” ir-
radiations and therefore lends itself to a calculation of 
the structure of the tracks of single particles in biolog-
ical matter. 
4. Particle tracks in biological matter
According to track theory, an ion of atomic number 
Z, effective charge number z*, given by
z* = Z[1 – e–125βZ–2/3],                       (5) 
when moving at speed β relative to the speed of light, 
has probability P for inactivating a cell whose nucleus it 
threads, given by
P = [1 – e–z*2/κβ2]m.                              (6) 
For T-1 cells, aerobically irradiated, κ = 1000 and m = 
2.5. Equation (6) describes the inactivation probabil-
ity in the “grain-count” regime, where inactivated cells 
lie along the ion’s path, like beads on a string. Inter-
ested only in relatively low Z particles, we can here ne-
glect the “track-width” regime. With the aid of equa-
tion (6), knowledge of the radiosensitivity parameters 
κ, m [7,21] and N0, and a table of residual range R vs. β 
in water, we are able to construct a picture of the track 
of a heavy ion in biological matter with inactivation as 
the end-point. 
To simulate a track we divide the path of the ion into 
range intervals li, at β = 0, 0.01, 0.02, . . . and find Pi from 
βi at the high energy end-point of each interval. If the 
average distance between the centers of the cells is λ, 
then the average number of cells in the i th interval is li/
λ, and the average number of cells killed in the i th inter-
val is Pili/λ. These cells are placed at random in the i th 
interval. 
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Figure 1 shows particle tracks constructed for cells 
having the radiosensitivity parameters of aerobically 
irradiated T-1 kidney cells. These are assumed to form 
a close packed structure with N0 = 106 cells/mm3 and 
with cell spacing λ = 10 μm. Track segments 1 mm long 
are shown, at selected ranges, slowing down from right 
to left, for ions from protons to argon. 
Particle Tracks in “Close Packed” T-1 Human Kidney Cells (Aerobic)
in 1 mm segments
‡ indicates position of Bragg peak. 
Each cell is taken to have a diameter of 10 microns, with the leftmost end of the first cell at the residual 
range indicated at left. Cells are close-packed and aligned along the ion’s path. 
 indicates a cell killed by a heavy ion moving from right to left, in the “ion-kill mode.”
 indicates a cell whose nucleus has been intersected by the moving heavy ion and which experiences 
only sub-lethal damage. 
Figure 1. Schematic simulation of the tracks of heavy ions in an “emulsion” of aligned, close-packed cells (at 10 μm intervals) hav-
ing the radiosensitivity parameters of aerobically irradiated T-1 kidney cells. 
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Figure 2. Γ (= ∫PdR) in cm, vs. range T, in cm, for different ions 
in a cellular matrix. The average number of cells killed by an 
ion of residual range R is found by dividing Γ by the average 
distance between intersections, λ. The fraction of intersected 
cells killed by an ion is Γ/R. 
A second representation of these data is given in Fig-
ure 2, displayed in a different manner. Using the same 
formulation we calculate Γ = ∑Pili and R = ∑ li . Since Γ/
R is the fraction of intersected cells inactivated by a par-
ticle of range R, the 45° line represents residual range 
values at which each traversed cell will be killed. Multi-
plying Γ/R by the total number of cells along the parti-
cle range, R/λ, the number of cells inactivated by a par-
ticle of residual range R will be Γ/λ. 
We must issue a cautionary note about the quality of 
the simulation at the very end of the track, where the 
range of delta-rays may be too small to bathe even sev-
eral of the sensitive elements of a cell, let alone an entire 
cell nucleus, as may be seen from equation (2). A similar 
cautionary note deals with cells whose nuclei are barely 
grazed by the ion’s path, but which may be inactivated 
by its delta-rays, as we see from equation (1). Taking C1 
there to be 130 Gy nm2, we calculate that an 86Rn ion at 
β = 0.15, with T = 10.66 MeV/amu, has z*2/β2 = 1.255 × 
105. This leads to tmax = 12.6 μm, and to a local dose of 
1.8 Gy at t = 3 μm. The existence of a predicted cellular 
track-width regime has recently been verified with bac-
terial spores [27] and yeast cells [28]. 
Experiments by Goodhead et al. [29] yield the esti-
mate that helium ions at 90 keV/μm produce 0.03 to 0.06 
lethal lesions/μm through nuclei 7 μm thick in mamma-
lian cells. This finding is in reasonable agreement with 
our calculation for T-1 kidney cells, where we find P = 
0.36 at β = 0.06, where the stopping power is 77 keV/μm. 
Experiments by Datta et al. [30] with 24lAm alpha parti-
cles find that the greatest inactivation probability for he-
lium ions which stop in the nucleus of a cell is 0.43, and 
that this probability drops both for lower and for higher 
energies. For comparison our estimate for a helium ion 
having a range of 8 μm is 0.8. Experiments by Lloyd et 
al. [31] give similar results. There are some interpretive 
problems associated with the determination of the cross-
sectional area of a plated nucleus, estimated by differ-
ent investigators as from 40 to 300 μm2, leading to dis-
crepancies in the estimated probability for killing by an 
alpha particle. Thus there are problems which remain 
unsolved in both calculation and measurement. Within 
this grey area, however, calculation and experimental 
results agree, even for stopping helium ions. Contrary 
to the situation with alpha particles, there are unfortu-
nately no comparable experimental data for protons. In 
Figure 1 we have represented the last cell whose nucleus 
is intersected by a proton as killed. This is an overesti-
mate, for our calculations indicate that the probability of 
killing the last intersected cell is about 1/3. Once again, 
at the very end of the track these calculations probably 
overestimate cell killing because of the limited range of 
the delta rays. For example, tmax = 0.23 μm at the resid-
ual proton range of 6.7 μm. But the diameter of the cell 
nucleus may be 8 μm. 
The tracks of heavier ions, with cell killing as the end-
point present no particular problems, for all intersected 
cells are killed at the very end of the track, where the 
greatest uncertainties exist in the calculation. We will re-
turn to this point in our discussion of cancer induction. 
Since cancer cannot be induced in killed cells, a question 
must be raised about the high values assigned to the 
quality factor at the highest “LET.” 
5. Electron tracks
The evaluation of track structure for electrons in bi-
ological systems poses a difficult problem. The funda-
mental question is:  Can a single electron kill a cell? It 
is not enough to say that at track-end electrons are high 
“LET” particles. As Lloyd et al. [31] have pointed out, 
we must consider the probability per unit path length. 
And “high LET electrons” have a very limited residual 
range. 
Track theory starts from the response of a bulk me-
dium to a dose of low “LET” radiation (gamma-rays), a 
tangle of electron tracks, and maps this response about 
the path of a heavy ion. It therefore does not speak di-
rectly to the question of the formation of electron tracks. 
To do so requires a theory of electron action cross-sec-
tions and a connection between these cross-sections and 
a macroscopic dose-effect relationship for a bulk me-
dium. This is a task for future research. 
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In the framework of the present theory we can esti-
mate the effect of an electron on a biological system by 
calculating the probability for cell killing for a “pseudo-
electron,” a particle having the charge and mass of an 
electron which behaves in accordance with expressions 
derived for and tested with heavy ions. Applying equa-
tion (6) to this problem, and neglecting branching sec-
ondary electrons of sufficient energy to form tracks of 
their own, we conclude that Γ = 2.3 × 10–2 μm for a 1 
MeV pseudo-electron (range in water about 4 mm) and 
2.2 × 10–2 μm for a 15 keV pseudo-electron. It is only at 
track end that such a particle has even a slight chance of 
killing a cell. However, when an electron moves slowly 
enough that the probability of inactivating a cell is large, 
its residual range is very small. Taking the mean spacing 
between cells to be 10 μm, this particle can be expected 
to kill 2.2 × 10–3 cells in a close-packed medium, at 15 
keV and 2.3 × 10–3 cells at 1 MeV initial energy, neglect-
ing the production of energetic secondary electrons. 
These results are consistent with experimental find-
ings in microbeam irradiations with electrons of 15 keV 
initial energy, by Datta et al. [30] who found that about 
1,000 electrons incident on the cell over the area of the 
nucleus were required to kill a cell. Because of scatter-
ing, only about half of these electrons were estimated to 
have penetrated the nuclear membrane. This leads to an 
estimate that the maximum probability for cell killing by 
track-end electrons is 2 × 10–3, for 15 keV electrons were 
more effective than incident electrons of either higher or 
lower energies in these experiments. As always in any 
high fluence experiment, we cannot be certain that the 
effect is produced from a single incident electron (ion-
kill) rather than the cumulative effect of several incident 
electrons (gamma-kill). Nor should we infer that a sin-
gle electron action is involved from the apparent coin-
cidence between action cross-sections and the physical 
size of a possible target, as has been suggested by Cole 
et al. [32], since action cross-sections may be an order of 
magnitude greater or smaller than the actual cross-sec-
tional area of the target [7,8]. Nevertheless the upper 
limit established by experiment for the probability that a 
15 keV electron inactivates cells agrees with the calcula-
tion for “pseudo-electrons.” 
Another way of approaching the problem is through 
the measured initial slope of survival curves after elec-
tron or gamma-ray irradiation. If an electron of initial 
energy w and all its secondaries kills v cells when fully 
absorbed in a matrix containing N0 cells per unit volume 
in a medium of unit density, the initial slope  of the 
dose-effect survival curve is given as
 = v/N0w.                                    (7) 
This result is obtained by noting that an irradiation with a 
fluence of F electrons per unit mass, of initial energy w de-
posits a dose D = Fw, while if each electron and all its sec-
ondaries kills v cells, the fraction of cells killed is Fv/N0. 
Inserting these quantities into the usual expression for 
the initial slope of the survival curve N/N0 = 1 – D + . . . 
leads to equation (7). 
Typical in-vitro experiments with mammalian cells 
contain a maximum concentration of 105 cells/ml [33]. 
Then, if 1 MeV electrons produce a survival curve with 
initial slope  = 10–5 Gy–1 derived from gamma-irradia-
tion of V-79 cells [34], we find v = 1.6 × 10–6 cells killed 
per incident electron and all its secondaries. In these ex-
periments much energy is deposited in the culture me-
dium. To evaluate the effect of a single electron in a cell 
culture from which the medium has been extracted, or 
for in-vivo tissue experiments, we suppose that N0 = 109 
cells/ml, leading to a value of v that is 104 times greater 
than before. Then a 1 MeV electron and all its secondar-
ies might kill 1.6 × 10–2 cells when  = 10–5 Gy–1. 
We must conclude that an electron does not make 
an observable track in tissue, even for a survival curve 
whose initial slope is 10 times greater than that for 
which the calculation is made. At most an occasional 
single cell is inactivated at path end in such a way that 
it would be impossible to identify observationally with 
single electrons. 
6. Other biological end-points
Contrary to cell killing we do not have radiosensitiv-
ity parameters for other end-points, such as DNA double 
strand breaks, G-2 block, chromosome breaks, transfor-
mation, or mutation. At best we can estimate response 
relative to cell killing from data like that presented by 
Cole et al. [32], which indicates that transformation and 
mutation are about 1/400 and 1/40000, respectively, as 
likely as lethality from a single alpha particle. On the 
other hand double strand breaks are about 10 times 
more likely than lethality, while G-2 block and chromo-
some breaks only about 3 times. For 1 MeV electrons 
and all their progeny we can estimate that 1 electron in 
24,000 would yield a transformed cell, while one elec-
tron in 2,400,000 would yield a mutation. 
For such rare events the problem arises that “track” 
loses its proper meaning as an observable entity. A par-
ticle track can also be regarded as the probability dis-
tribution for a defined end-point along an ion’s path, 
which becomes observable only if the probability ex-
ceeds a certain level. For very low probabilities a spec-
ified biological effect in a single cell is likely to arise by 
the cooperative action of two or more electrons passing 
through the nucleus of the cell when this leads to a joint 
probability of appropriate value. 
From all the different biological end-points, cancer 
induction represents the most important somatic haz-
ard in radiation protection. We thus wish to explore the 
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question: What is the probability for a 1 MeV electron 
to cause a cancer? Since transformation toward malig-
nancy is regarded as the initial event in carcinogenesis, 
in-vitro transformation experiments can supply part of 
the needed information. Thus we will get an upper limit 
for the probability for cancer induction, because not ev-
ery transformed cell will develop a tumor. From these 
data we can derive a probability for transforming a cell 
by a single 1 MeV electron of between 10–4 and 10–5 at 
the very end of the path [32,35]. 
On the other hand a considerable amount of exper-
imental data on cancer frequencies at low doses have 
been compiled in epidemiological studies during recent 
years [1]. This epidemiological approach considers also 
all the synergistic biological mechanisms involved in in-
vivo irradiation as compared to in-vitro transformation 
experiments with cell cultures. If we take the cancer risk 
to be 10 cancers per rad per 106 persons, as an average 
value for different organs and types of radiations [1,36], 
a radiation sensitive organ of 104 mm3 having 106 cells/
mm3 of equal susceptibility, then the probability of can-
cer induction per cell and per rad is 10–15. If a dose of 1 
rad (0.06 MeV/cell) were delivered by 1 MeV electrons 
(having a path length in tissue of about 4.3 mm and thus 
traversing about 430 cells), then about 430 electrons of 1 
MeV initial energy must pass through a cell to deposit 1 
MeV of energy, or at 1 rad about 25 electrons intersect 
the cell. Combining these numbers the probability (on 
average) that a single 1 MeV electron intersecting a cell 
can lead to an observable tumor is about 4 × 10–17. 
Converting the data of Mole [37] for leukemia inci-
dence in Japanese atom bomb survivors (typically ex-
posed to doses exceeding 20 rad), a comparable prob-
ability that a 1 MeV electron passing through a bone 
marrow cell will lead to leukemia is about 10–18. 
Under the assumption [7] that the transformation 
cross-section equals the product of the cross-sectional 
area of the cell nucleus (10–10 m2) by the probability of 
transformation, we find that the above derived probabil-
ities yield a mean transformation (action) cross-section 
for a 1 MeV electron of about 10–23 cm2. This cross-sec-
tion represents only a mean value, since it is averaged 
over the path length of an electron and neglects the fact 
that there is a latency period of about 10 to 20 years be-
tween the initiating energy deposition events and the 
manifestation of the tumor. 
Transformation probabilities for alpha particles in the 
energy range of 1-2 MeV/amu are about 10–13 for lung 
cancer caused by inhaled radon decay products in man 
[38], and between 10–9 to 10–11 for bone cancer in man 
by 239Pu alpha particles [39]. These numbers lead to av-
erage transformation cross-sections between 10–15 and 
10–19 cm2. Assuming a quality factor of 20, and allow-
ing for differences in LET and particle range, alpha par-
ticle cross-sections show fair agreement with the elec-
tron data. However, all epidemiological in-vivo values 
are about 1012 times smaller than for in-vitro transforma-
tion. Since not all cells in an irradiated tissue volume are 
likely to be susceptible to malignant transformation, the 
actual probability will be higher by some orders of mag-
nitude. Nevertheless, these numbers are still so very 
small compared to atomic cross-sections as to suggest 
contradiction. One possibility is that the linear extrapo-
lation to low doses is invalid. An equivalent interpreta-
tion is that more than 1 electron or alpha particle must 
interact with the nucleus of a cell to induce malignant 
transformation. 
Allowing for concomitant cell sterilization, the ob-
served tumor frequency represents always the prod-
uct of two probabilities, for transformation and for not 
being killed [40]. Having in mind that cell killing has a 
much higher probability than transformation, then in 
order to get the observed linear dose-effect relationship 
in the low dose region, the induction process must be 
a power function of dose, as the result of the coopera-
tion of at least two energy deposition events. This has 
already been pointed out by Mole [37], who concludes 
that for leukemia incidence in Japanese bomb survivors, 
cancer induction is most probably a function of dose 
squared. For the production of osteosarcoma by alpha 
particles of radium in man, Marshall and Groer [41] put 
forward a theory which postulates two initiation events 
produced in a single cell by two alpha particles. Lloyd et 
al. [35] observed even a nearly cubic dose response for 
transformation of mouse embryo cells (CH 10T1/2) with 
5.6 MeV alpha particles. Thus for electrons there is suffi-
cient evidence that at least two energy deposition events 
(from two different electrons) in a cell are a necessary 
condition for carcinogenesis [40]. An equivalent inter-
pretation, particularly for high LET radiation, might be 
that induction results from the transformation of two 
different transformed and most probably adjacent cells. 
However, it is important to note here that specific bio-
logical differences between different kinds of malig-
nant disease may play an important role in their induc-
tion and consequently in their interpretation in terms of 
dose-effect relationships. 
We wish to suggest yet a new line of evidence re-
garding the character of the dose-response curve 
which we believe has not yet been considered, namely, 
does one observe single or multiple tumor sites in ra-
diation induced cancer. For doses causing an effect 
above the background level, many-hit processes have 
a steeper dose-response curve than single hit processes 
[12]. Hence the probability increment for many-hit 
processes per increment in dose may be substantially 
greater than for single hit processes. Since the number 
of cells at risk is the same, we would expect that mul-
tiple tumors are more common if the transformation 
leading to carcinogenesis is a many-hit process. Ob-
servations of site multiplicity have never been prop-
erly reported, but this sort of information may prove of 
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value in understanding the shape of the dose-response 
curve at low doses. 
Note that our track analyses of epidemiological data 
imply that cancer induction is a statistical process, like 
the exposure of photographic film. In both cases there 
is no threshold, by definition. There is only an expo-
sure level at which the probability exceeds background. 
This is sometimes mistakenly identified as a threshold 
exposure. 
Because of the competitive effect of cell killing, occur-
ring with much higher probability, we can estimate the 
probability for transformation along the path of differ-
ent energetic charged particles with the use of Figures 
1 and 2. There we see that heavy nuclei can only cause 
cancer at very high energies because all intersected cells 
are killed at lower energies. On the other hand, protons, 
deuterons, and alpha particles kill cells only at the very 
end of their range, being effective therefore to induce a 
cancer in the preceding part of their path. This allows 
us to estimate the probability for cancer induction from 
a single neutron, using information about the second-
ary particle spectrum in tissue [42,43]. There we see that 
for 14 MeV neutrons, only protons, and to a lesser extent 
also alpha particles can transform a cell. For 1 MeV neu-
trons, only protons can transform a cell (with the excep-
tion of the last cell in the path), since all heavier second-
aries, e.g. B, C, N, and O nuclei have residual ranges at 
which all cells are killed. 
To repeat some of these conclusions for emphasis. 
These calculations have demonstrated that cell kill-
ing is the dominant mode of action for the intersection 
of high LET particles with cells. Transformation and 
carcinogenesis can only take place in surviving cells. 
A track structure interpretation of low dose effects 
which result from single intersections of cells there-
fore strongly suggests that the quality factor for radia-
tion induced carcinogenesis should be smaller for high 
LET particles than for low LET radiations, practically 
indistinguishable from zero for heavy charged parti-
cles. This raises doubts about whether cell killing is ac-
tually an important end-point for radiation protection 
purposes, especially at low dose levels where only few 
cells are affected by heavy ions, if the cells intersected 
by the path of an ion can create no subsequent difficul-
ties in later cell generations. 
7. Conclusion
Biological effects of low doses of ionizing radiation 
have been reconsidered in the new and somewhat dif-
ferent light of the structure of particle tracks along the 
path of a single ion. In the calculations presented here, it 
is always assumed that a single cell is the sensitive site 
for a defined biological end-point, thus disregarding in-
ter-cellular effects. 
No particular conceptual problems are presented 
by 1-hit detectors, or by cell-killing with heavy ions. In 
these cases there is clearly an initial slope demanded by 
track structure theory and observed experimentally. 
Questions, however, must be raised about the re-
sponse of cells to electrons and other low “LET” radi-
ations, about other biological end-points than cellular 
inactivation. One can only suggest that quantitative re-
sults like those found here should stimulate qualitative 
speculations. 
When, on the average, at most only one in a hun-
dred or one in a million 1 MeV electrons incident on a 
single cell produces an observable effect in tissue, it is 
reasonable to ask whether indeed the action probabil-
ity is not negligibly small and whether the observed ef-
fect does not arise from the cooperative effect of several 
electrons which interact with the nucleus of a cell. From 
the track structure analysis we find new bases for con-
sidering whether a low probability for a biological event 
is unacceptably and implausibly low, contradicting the 
linear extrapolation from which it was calculated. The 
new bases of comparison are the known cross-sections 
for nuclear, atomic, and molecular processes. When an 
action cross-section for a biological process is orders of 
magnitude below molecular cross-sections, when it even 
approaches nuclear cross-sections, we deem it to be un-
acceptably low. We conclude that there is an error in the 
logical chain which led to the inferred value of the bio-
logical cross-section. The numerical values of the cross-
section we have inferred from these calculations, from 
the linear extrapolation to low dose, lead us to support 
the view that cancer induction is a “many-hit” process 
for electrons, and is at least a “2-hit” process for alpha 
particles. Especially for alpha particles we must note 
that to achieve two hits, that is two interactions leading 
to the end-point, may require more than two alpha par-
ticle passages through the nucleus of a cell. We find no 
basis for either a linear or a linear-quadratic extrapola-
tion to low doses. And because of the statistical nature 
of these processes, we find no basis for a threshold dose. 
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